Activation of cGMP/PKG/p65 signaling associated with PDE5‐Is downregulates CCL5 secretion by CD8 + T cells in benign prostatic hyperplasia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Activation of cGMP/PKG/p65 signaling associated with PDE5‐Is downregulates CCL5 secretion by CD8 + T cells in benign prostatic hyperplasia

Published:2019-04-08 Issue:8 Volume:79 Page:909-919
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Jin Song¹²³^ORCID,Xiang Peng¹²³,Liu Jie¹²³,Yang Yang¹²³,Hu Shuai¹²³^ORCID,Sheng Jindong¹²³,He Qun¹²³,Yu Wei¹²³,Han Wenke¹²³,Jin Jie¹²³,Peng Jing¹²³

Affiliation:

1. Department of UrologyPeking University First Hospital and Institute of Urology, Peking UniversityBeijing China

2. National Research Center for Genitourinary OncologyBeijing China

3. Beijing Key Laboratory of Urogenital Diseases (male)Molecular Diagnosis and Treatment CenterBeijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23801

Reference36 articles.

1. Critical Analysis of the Relationship Between Sexual Dysfunctions and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

2. A Systematic Review and Meta-analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with α-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

3. Monotherapy with Tadalafil or Tamsulosin Similarly Improved Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in an International, Randomised, Parallel, Placebo-Controlled Clinical Trial

4. Time to Onset of Clinically Meaningful Improvement with Tadalafil 5 mg Once Daily for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Analysis of Data Pooled from 4 Pivotal, Double-Blind, Placebo Controlled Studies

5. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a 1-year, open-label extension study

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A 2‐week treatment with 5‐azacytidine improved the hypercontractility state in prostate from obese mice: Role of the nitric oxide‐cyclic guanosine monophosphate signalling pathway;Clinical and Experimental Pharmacology and Physiology;2024-03-07

2. Gene expression of hemostasis biomarkers following HIIT and RIPC;Comparative Clinical Pathology;2024-02-06

3. Integrated high-throughput analysis identifies super enhancers in metastatic castration-resistant prostate cancer;Frontiers in Pharmacology;2023-05-24

4. A Novel Insight into the Immune-Related Interaction of Inflammatory Cytokines in Benign Prostatic Hyperplasia;Journal of Clinical Medicine;2023-02-24

5. Benign Prostatic Hyperplasia/Obstruction Ameliorated Using a Soluble Guanylate Cyclase Activator;The Journal of Pathology;2021-12-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3